MIM Fertility

MIM Fertility, founded in 2019, is a Polish deeptech startup specializing in AI-powered software platforms for IVF clinics and labs. Its flagship products, EMBRYOAID and FOLLISCAN, utilize cutting-edge AI and machine learning technology to optimize fertility procedures, offering more accurate diagnosis and treatment, reduced time and cost, and improved outcomes for patients. The company boasts a team of 25+ award-winning Polish ML experts and international fertility professionals, with a strong emphasis on scientific research and innovation in the fertility field. The recent $2.00M Seed Round investment in December 2023 by Tangent Line Ventures and Peleton underscores investor confidence in MIM Fertility’s groundbreaking technology. Their cloud-based platform, FOLLISCAN, not only automates follicle identification and measurement during ultrasound but also extends quality healthcare to underserved patients in remote areas, eliminating geographical barriers to medical expertise. On the other hand, EMBRYOAID assesses the implantation potential of human embryos, offering comprehensive AI tools for day-5 embryo evaluation and advanced IVF analytics. Their commitment to innovation and impactful solutions positions MIM Fertility as a promising player in the fertility tech industry.